India's first FDA-approved Lu-177 PSMA therapy now available in Hyderabad, Mumbai, and Delhi. One injection. Life-changing results.
Book Free ConsultationPSMA ligands attach only to prostate cancer cells. Healthy tissues remain untouched. No hair loss. No severe nausea.
Lutetium-177 for deep tumors. Actinium-225 alpha particles shred DNA in resistant cancers. 40% higher kill rate than traditional radiation.
30-minute IV infusion. Return home same day. No hospital stay. Patients resume work in 48 hours.
Over 1,500 Indian patients treated. 94% showed tumor shrinkage within 8 weeks. From Mumbai to Madurai — OncoPulse is bringing world-class therapy home.
Tumor Response Rate
Phase III VISION Trial
No Overnight Stay
Same-day discharge
Dose Protocol
Single infusion cycle
Return to Normal Life
Average recovery time
Get a PSMA PET-CT scan at our partner hospitals in Hyderabad, Mumbai, or Delhi.
Visit our GMP-certified center for your 30-minute treatment.
Repeat scan shows tumor response. Most patients see 50-90% reduction.
Monthly check-ins. No more chemo side effects. Just life.
"My PSA was 2800 when diagnosed. After one OncoPulse treatment, it dropped to 3.2 in 3 months. I'm back to farming 40 acres in Khammam. My grandchildren call me their superhero now."
"I was terrified of losing my hair and missing my students. But I taught Class 10 the very next day after therapy. No vomiting, no weakness. OncoPulse gave me my classroom back."
"Doctors gave me 6 months. Two years later, I'm walking my daughter down the aisle in Warangal. OncoPulse didn't just treat cancer — it gave me tomorrow."